In the course of our research program to develop novel muscarinic receptor antagonists for the treatment of COPD, new tropane carbamate derivatives were identified as potent anti-muscarinic agents. The synthesis, structure-activity relationships and pharmacological evaluation that led to the identification of compound 5o, are described.
在我们开发用于治疗
COPD的新型毒蕈碱受体拮抗剂的研究计划过程中,新的托烷
氨基甲酸酯衍
生物被确定为有效的抗毒蕈碱剂。描述了导致化合物5o鉴定的合成,构效关系和药理学评估。